Ranking · Molecular
Genes with curated or cohort evidence
Distinct genes linked to this cancer (or descendants) by an accepted CIViC evidence item or by a GDC cohort frequency of at least 5% with ≥ 20 affected cases.
Computedci-genes-v1unit: counthigher = betterAll metrics
| Rank | Δ | Cancer | Genes with curated or cohort evidence (count) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Neoplasm | 3,505 | 100 | Medium confidence | civicgdc | inputs
ranking row 2590355 |
| 2 | = | Carcinoma | 2,591 | 99.8 | Medium confidence | civicgdc | inputs
ranking row 2590356 |
| 3 | = | Carcinoma of Unknown Primary | 2,052 | 99.6 | Medium confidence | civicgdc | inputs
ranking row 2590359 |
| 3 | = | Malignant Neoplasm of Unknown Primary | 2,052 | 99.6 | Medium confidence | civicgdc | inputs
ranking row 2590358 |
| 3 | = | Secondary Malignant Neoplasm | 2,052 | 99.6 | Medium confidence | civicgdc | inputs
ranking row 2590357 |
| 6 | = | Adenocarcinoma | 1,874 | 99 | Medium confidence | civicgdc | inputs
ranking row 2590360 |
| 7 | = | Malignant Genitourinary System Neoplasm | 1,313 | 98.8 | Medium confidence | civicgdc | inputs
ranking row 2590361 |
| 8 | = | Genitourinary System Carcinoma | 1,293 | 98.7 | Medium confidence | civicgdc | inputs
ranking row 2590362 |
| 9 | = | Digestive System Carcinoma | 1,038 | 98.5 | Medium confidence | civicgdc | inputs
ranking row 2590364 |
| 9 | = | Malignant Digestive System Neoplasm | 1,038 | 98.5 | Medium confidence | civicgdc | inputs
ranking row 2590363 |
| 11 | = | Digestive System Adenocarcinoma | 886 | 98.1 | Medium confidence | civicgdc | inputs
ranking row 2590365 |
| 12 | = | Malignant Reproductive System Neoplasm | 812 | 97.9 | Medium confidence | civicgdc | inputs
ranking row 2590366 |
| 13 | = | Malignant Lung Neoplasm | 803 | 97.7 | Medium confidence | civicgdc | inputs
ranking row 2590369 |
| 13 | = | Malignant Respiratory System Neoplasm | 803 | 97.7 | Medium confidence | civicgdc | inputs
ranking row 2590367 |
| 13 | = | Malignant Thoracic Neoplasm | 803 | 97.7 | Medium confidence | civicgdc | inputs
ranking row 2590368 |
| 16 | = | Malignant Urinary System Neoplasm | 799 | 97.1 | Medium confidence | civicgdc | inputs
ranking row 2590370 |
| 16 | = | Urinary System Carcinoma | 799 | 97.1 | Medium confidence | civicgdc | inputs
ranking row 2590371 |
| 18 | = | Malignant Female Reproductive System Neoplasm | 707 | 96.7 | Medium confidence | civicgdc | inputs
ranking row 2590372 |
| 19 | = | Lung Carcinoma | 704 | 96.5 | Medium confidence | civicgdc | inputs
ranking row 2590373 |
| 20 | = | Lung Non-Small Cell Carcinoma | 702 | 96.3 | Medium confidence | civicgdc | inputs
ranking row 2590375 |
| 20 | = | Non-Small Cell Carcinoma | 702 | 96.3 | Medium confidence | civicgdc | inputs
ranking row 2590374 |
| 22 | = | Female Reproductive System Carcinoma | 686 | 96 | Medium confidence | civicgdc | inputs
ranking row 2590376 |
| 23 | = | Melanoma | 672 | 95.8 | Medium confidence | civicgdc | inputs
ranking row 2590377 |
| 24 | = | Malignant Uterine Neoplasm | 630 | 95.6 | Medium confidence | civicgdc | inputs
ranking row 2590378 |
| 25 | = | Malignant Skin Neoplasm | 599 | 95.4 | Medium confidence | civicgdc | inputs
ranking row 2590379 |
| 26 | = | Colorectal Adenocarcinoma | 529 | 95.2 | Medium confidence | civicgdc | inputs
ranking row 2590383 |
| 26 | = | Colorectal Carcinoma | 529 | 95.2 | Medium confidence | civicgdc | inputs
ranking row 2590384 |
| 26 | = | Intestinal Carcinoma | 529 | 95.2 | Medium confidence | civicgdc | inputs
ranking row 2590381 |
| 26 | = | Malignant Colorectal Neoplasm | 529 | 95.2 | Medium confidence | civicgdc | inputs
ranking row 2590385 |
| 26 | = | Malignant Intestinal Neoplasm | 529 | 95.2 | Medium confidence | civicgdc | inputs
ranking row 2590380 |
| 26 | = | Malignant Large Intestinal Neoplasm | 529 | 95.2 | Medium confidence | civicgdc | inputs
ranking row 2590382 |
| 32 | = | Cutaneous Melanoma | 511 | 94 | Medium confidence | civicgdc | inputs
ranking row 2590386 |
| 33 | = | Lung Adenocarcinoma | 497 | 93.8 | Medium confidence | civicgdc | inputs
ranking row 2590388 |
| 33 | = | Lung Non-Squamous Non-Small Cell Carcinoma | 497 | 93.8 | Medium confidence | civicgdc | inputs
ranking row 2590389 |
| 33 | = | Non-Small Cell Adenocarcinoma | 497 | 93.8 | Medium confidence | civicgdc | inputs
ranking row 2590387 |
| 36 | = | Invasive Carcinoma | 496 | 93.3 | Medium confidence | civicgdc | inputs
ranking row 2590391 |
| 36 | = | Invasive Malignant Neoplasm | 496 | 93.3 | Medium confidence | civicgdc | inputs
ranking row 2590390 |
| 36 | = | Kidney Carcinoma | 496 | 93.3 | Medium confidence | civicgdc | inputs
ranking row 2590394 |
| 36 | = | Malignant Kidney Neoplasm | 496 | 93.3 | Medium confidence | civicgdc | inputs
ranking row 2590392 |
| 36 | = | Renal Cell Carcinoma | 496 | 93.3 | Medium confidence | civicgdc | inputs
ranking row 2590395 |
| 36 | = | Urinary System Adenocarcinoma | 496 | 93.3 | Medium confidence | civicgdc | inputs
ranking row 2590393 |
| 42 | = | Squamous Cell Carcinoma | 479 | 92.1 | Medium confidence | civicgdc | inputs
ranking row 2590396 |
| 43 | = | Endometrial Carcinoma | 463 | 91.9 | Medium confidence | civicgdc | inputs
ranking row 2590397 |
| 43 | = | Malignant Endometrial Neoplasm | 463 | 91.9 | Medium confidence | civicgdc | inputs
ranking row 2590399 |
| 43 | = | Malignant Uterine Corpus Neoplasm | 463 | 91.9 | Medium confidence | civicgdc | inputs
ranking row 2590398 |
| 46 | = | Esophageal and Gastroesophageal Junction Carcinoma | 446 | 91.3 | Medium confidence | civicgdc | inputs
ranking row 2590400 |
| 47 | = | Head and Neck Carcinoma | 440 | 91.2 | Medium confidence | civicgdc | inputs
ranking row 2590402 |
| 47 | = | Malignant Head and Neck Neoplasm | 440 | 91.2 | Medium confidence | civicgdc | inputs
ranking row 2590401 |
| 49 | = | Hepatopancreatobiliary Carcinoma | 426 | 90.8 | Medium confidence | civicgdc | inputs
ranking row 2590403 |
| 50 | = | Bladder Carcinoma | 410 | 90.6 | Medium confidence | civicgdc | inputs
ranking row 2590410 |
| 50 | = | Bladder Urothelial Carcinoma | 410 | 90.6 | Medium confidence | civicgdc | inputs
ranking row 2590407 |
| 50 | = | Malignant Bladder Neoplasm | 410 | 90.6 | Medium confidence | civicgdc | inputs
ranking row 2590408 |
| 50 | = | Malignant Urinary Tract Neoplasm | 410 | 90.6 | Medium confidence | civicgdc | inputs
ranking row 2590405 |
| 50 | = | Transitional Cell Carcinoma | 410 | 90.6 | Medium confidence | civicgdc | inputs
ranking row 2590404 |
| 50 | = | Urinary Tract Carcinoma | 410 | 90.6 | Medium confidence | civicgdc | inputs
ranking row 2590409 |
| 50 | = | Urothelial Carcinoma | 410 | 90.6 | Medium confidence | civicgdc | inputs
ranking row 2590406 |
| 57 | = | Gastroesophageal Junction Adenocarcinoma | 384 | 89.2 | Medium confidence | civicgdc | inputs
ranking row 2590411 |
| 57 | = | Gastroesophageal Junction Carcinoma | 384 | 89.2 | Medium confidence | civicgdc | inputs
ranking row 2590412 |
| 57 | = | Lymphoid Neoplasm | 384 | 89.2 | Medium confidence | civicgdc | inputs
ranking row 2590413 |
| 60 | = | Lymphoma | 382 | 88.7 | Medium confidence | civicgdc | inputs
ranking row 2590414 |
| 60 | = | Non-Hodgkin Lymphoma | 382 | 88.7 | Medium confidence | civicgdc | inputs
ranking row 2590415 |
| 62 | = | B-Cell Malignant Neoplasm | 381 | 88.3 | Medium confidence | civicgdc | inputs
ranking row 2590416 |
| 63 | = | B-Cell Non-Hodgkin Lymphoma | 379 | 88.1 | Medium confidence | civicgdc | inputs
ranking row 2590417 |
| 64 | = | Colon Adenocarcinoma | 369 | 87.9 | Medium confidence | civicgdc | inputs
ranking row 2590418 |
| 64 | = | Colon Carcinoma | 369 | 87.9 | Medium confidence | civicgdc | inputs
ranking row 2590419 |
| 64 | = | Malignant Colon Neoplasm | 369 | 87.9 | Medium confidence | civicgdc | inputs
ranking row 2590420 |
| 67 | = | Gastric Adenocarcinoma | 364 | 87.3 | Medium confidence | civicgdc | inputs
ranking row 2590423 |
| 67 | = | Gastric Carcinoma | 364 | 87.3 | Medium confidence | civicgdc | inputs
ranking row 2590422 |
| 67 | = | Malignant Gastric Neoplasm | 364 | 87.3 | Medium confidence | civicgdc | inputs
ranking row 2590421 |
| 70 | = | Cervical Carcinoma | 358 | 86.7 | Medium confidence | civicgdc | inputs
ranking row 2590424 |
| 70 | = | Malignant Cervical Neoplasm | 358 | 86.7 | Medium confidence | civicgdc | inputs
ranking row 2590425 |
| 72 | = | Malignant Hepatobiliary Neoplasm | 329 | 86.3 | Medium confidence | civicgdc | inputs
ranking row 2590426 |
| 73 | = | Lung Squamous Cell Carcinoma | 324 | 86.2 | Medium confidence | civicgdc | inputs
ranking row 2590427 |
| 74 | = | Female Reproductive System Adenocarcinoma | 302 | 86 | Medium confidence | civicgdc | inputs
ranking row 2590428 |
| 75 | = | Breast Carcinoma | 278 | 85.8 | Medium confidence | civicgdc | inputs
ranking row 2590430 |
| 75 | = | Invasive Breast Carcinoma | 278 | 85.8 | Medium confidence | civicgdc | inputs
ranking row 2590431 |
| 75 | = | Malignant Breast Neoplasm | 278 | 85.8 | Medium confidence | civicgdc | inputs
ranking row 2590429 |
| 78 | = | Skin Carcinoma | 274 | 85.2 | Medium confidence | civicgdc | inputs
ranking row 2590432 |
| 79 | = | Endocrine Carcinoma | 268 | 85 | Medium confidence | civicgdc | inputs
ranking row 2590434 |
| 79 | = | Malignant Endocrine Neoplasm | 268 | 85 | Medium confidence | civicgdc | inputs
ranking row 2590433 |
| 81 | = | Pancreatobiliary Carcinoma | 242 | 84.6 | Medium confidence | civicgdc | inputs
ranking row 2590435 |
| 82 | = | Mature B-Cell Non-Hodgkin Lymphoma | 241 | 84.4 | Medium confidence | civicgdc | inputs
ranking row 2590436 |
| 83 | = | Head and Neck Squamous Cell Carcinoma | 239 | 84.2 | Medium confidence | civicgdc | inputs
ranking row 2590437 |
| 84 | = | Acute Leukemia | 217 | 84 | Medium confidence | civicgdc | inputs
ranking row 2590439 |
| 84 | = | Leukemia | 217 | 84 | Medium confidence | civicgdc | inputs
ranking row 2590438 |
| 84 | = | Liver Carcinoma | 217 | 84 | Medium confidence | civicgdc | inputs
ranking row 2590440 |
| 84 | = | Malignant Liver Neoplasm | 217 | 84 | Medium confidence | civicgdc | inputs
ranking row 2590441 |
| 84 | = | Primary Malignant Liver Neoplasm | 217 | 84 | Medium confidence | civicgdc | inputs
ranking row 2590442 |
| 89 | = | Hepatocellular Carcinoma | 216 | 83.1 | Medium confidence | civicgdc | inputs
ranking row 2590443 |
| 90 | = | Non-Clear Cell Renal Cell Carcinoma | 206 | 82.9 | Medium confidence | civicgdc | inputs
ranking row 2590446 |
| 90 | = | Papillary Adenocarcinoma | 206 | 82.9 | Medium confidence | civicgdc | inputs
ranking row 2590445 |
| 90 | = | Papillary Carcinoma | 206 | 82.9 | Medium confidence | civicgdc | inputs
ranking row 2590444 |
| 90 | = | Renal Non-Clear Cell Carcinoma | 206 | 82.9 | Medium confidence | civicgdc | inputs
ranking row 2590447 |
| 94 | = | Sarcoma | 204 | 82.1 | Medium confidence | civicgdc | inputs
ranking row 2590448 |
| 95 | = | Malignant Mixed Neoplasm | 202 | 81.9 | Medium confidence | civicgdc | inputs
ranking row 2590449 |
| 96 | = | Basal Cell Carcinoma | 200 | 81.7 | Medium confidence | civicgdc | inputs
ranking row 2590450 |
| 96 | = | Cervical Adenocarcinoma | 200 | 81.7 | Medium confidence | civicgdc | inputs
ranking row 2590452 |
| 96 | = | Cervical Non-Squamous Cell Carcinoma | 200 | 81.7 | Medium confidence | civicgdc | inputs
ranking row 2590457 |
| 96 | = | Endometrial Adenocarcinoma | 200 | 81.7 | Medium confidence | civicgdc | inputs
ranking row 2590455 |
| 96 | = | Endometrial Endometrioid Adenocarcinoma | 200 | 81.7 | Medium confidence | civicgdc | inputs
ranking row 2590456 |
| 96 | = | Endometrioid Adenocarcinoma | 200 | 81.7 | Medium confidence | civicgdc | inputs
ranking row 2590451 |
| 96 | = | Female Reproductive System Endometrioid Adenocarcinoma | 200 | 81.7 | Medium confidence | civicgdc | inputs
ranking row 2590453 |
| 96 | = | Skin Basal Cell Carcinoma | 200 | 81.7 | Medium confidence | civicgdc | inputs
ranking row 2590454 |
| 96 | = | Type I Endometrial Adenocarcinoma | 200 | 81.7 | Medium confidence | civicgdc | inputs
ranking row 2590458 |
| 105 | = | Malignant Neck Neoplasm | 194 | 80 | Medium confidence | civicgdc | inputs
ranking row 2590459 |
| 105 | = | Malignant Thyroid Gland Neoplasm | 194 | 80 | Medium confidence | civicgdc | inputs
ranking row 2590460 |
| 105 | = | Neck Carcinoma | 194 | 80 | Medium confidence | civicgdc | inputs
ranking row 2590461 |
| 105 | = | Thyroid Gland Carcinoma | 194 | 80 | Medium confidence | civicgdc | inputs
ranking row 2590462 |
| 109 | = | Skin Squamous Cell Carcinoma | 171 | 79.2 | Medium confidence | civicgdc | inputs
ranking row 2590463 |
| 110 | = | Malignant Anorectal Neoplasm | 163 | 79 | Medium confidence | civicgdc | inputs
ranking row 2590464 |
| 110 | = | Malignant Rectal Neoplasm | 163 | 79 | Medium confidence | civicgdc | inputs
ranking row 2590465 |
| 110 | = | Rectal Adenocarcinoma | 163 | 79 | Medium confidence | civicgdc | inputs
ranking row 2590466 |
| 110 | = | Rectal Carcinoma | 163 | 79 | Medium confidence | civicgdc | inputs
ranking row 2590467 |
| 114 | = | Invasive Prostate Carcinoma | 146 | 78.3 | Medium confidence | civicgdc | inputs
ranking row 2590468 |
| 114 | = | Male Reproductive System Carcinoma | 146 | 78.3 | Medium confidence | civicgdc | inputs
ranking row 2590469 |
| 114 | = | Malignant Male Reproductive System Neoplasm | 146 | 78.3 | Medium confidence | civicgdc | inputs
ranking row 2590470 |
| 114 | = | Malignant Prostate Neoplasm | 146 | 78.3 | Medium confidence | civicgdc | inputs
ranking row 2590472 |
| 114 | = | Prostate Adenocarcinoma | 146 | 78.3 | Medium confidence | civicgdc | inputs
ranking row 2590471 |
| 114 | = | Prostate Carcinoma | 146 | 78.3 | Medium confidence | civicgdc | inputs
ranking row 2590473 |
| 120 | = | Aggressive B-Cell Non-Hodgkin Lymphoma | 144 | 77.1 | Medium confidence | civicgdc | inputs
ranking row 2590474 |
| 120 | = | Aggressive Non-Hodgkin Lymphoma | 144 | 77.1 | Medium confidence | civicgdc | inputs
ranking row 2590476 |
| 120 | = | Non-Hodgkin Lymphoma by Clinical Course | 144 | 77.1 | Medium confidence | civicgdc | inputs
ranking row 2590475 |
| 123 | = | Biliary Tract Carcinoma | 141 | 76.5 | Medium confidence | civicgdc | inputs
ranking row 2590477 |
| 123 | = | Malignant Biliary Tract Neoplasm | 141 | 76.5 | Medium confidence | civicgdc | inputs
ranking row 2590478 |
| 125 | = | Cholangiocarcinoma | 140 | 76.2 | Medium confidence | civicgdc | inputs
ranking row 2590480 |
| 125 | = | Diffuse Large B-Cell Lymphoma | 140 | 76.2 | Medium confidence | civicgdc | inputs
ranking row 2590481 |
| 125 | = | Intraductal Papillary Neoplasm of the Bile Duct | 140 | 76.2 | Medium confidence | civicgdc | inputs
ranking row 2590482 |
| 125 | = | Malignant Bile Duct Neoplasm | 140 | 76.2 | Medium confidence | civicgdc | inputs
ranking row 2590479 |
| 129 | = | Esophageal Carcinoma | 138 | 75.4 | Medium confidence | civicgdc | inputs
ranking row 2590484 |
| 129 | = | Malignant Esophageal Neoplasm | 138 | 75.4 | Medium confidence | civicgdc | inputs
ranking row 2590483 |
| 131 | = | Malignant Bone Marrow Neoplasm | 132 | 75 | Medium confidence | civicgdc | inputs
ranking row 2590485 |
| 132 | = | Adrenal Cortical Carcinoma | 123 | 74.8 | Medium confidence | civicgdc | inputs
ranking row 2590489 |
| 132 | = | Malignant Adrenal Cortical Neoplasm | 123 | 74.8 | Medium confidence | civicgdc | inputs
ranking row 2590491 |
| 132 | = | Malignant Adrenal Gland Neoplasm | 123 | 74.8 | Medium confidence | civicgdc | inputs
ranking row 2590490 |
| 132 | = | Malignant Peritoneal and Retroperitoneal Neoplasm | 123 | 74.8 | Medium confidence | civicgdc | inputs
ranking row 2590486 |
| 132 | = | Malignant Retroperitoneal Neoplasm | 123 | 74.8 | Medium confidence | civicgdc | inputs
ranking row 2590487 |
| 132 | = | Retroperitoneal Carcinoma | 123 | 74.8 | Medium confidence | civicgdc | inputs
ranking row 2590488 |
| 138 | = | Myeloproliferative Neoplasm | 121 | 73.7 | Medium confidence | civicgdc | inputs
ranking row 2590492 |
| 139 | = | Acute Myeloid Leukemia | 119 | 73.5 | Medium confidence | civicgdc | inputs
ranking row 2590495 |
| 139 | = | Malignant Ovarian Epithelial Tumor | 119 | 73.5 | Medium confidence | civicgdc | inputs
ranking row 2590493 |
| 139 | = | Malignant Ovarian Neoplasm | 119 | 73.5 | Medium confidence | civicgdc | inputs
ranking row 2590496 |
| 139 | = | Malignant Ovarian Serous Tumor | 119 | 73.5 | Medium confidence | civicgdc | inputs
ranking row 2590497 |
| 139 | = | Myeloid Leukemia | 119 | 73.5 | Medium confidence | civicgdc | inputs
ranking row 2590494 |
| 139 | = | Ovarian Adenocarcinoma | 119 | 73.5 | Medium confidence | civicgdc | inputs
ranking row 2590500 |
| 139 | = | Ovarian Carcinoma | 119 | 73.5 | Medium confidence | civicgdc | inputs
ranking row 2590498 |
| 139 | = | Ovarian Serous Adenocarcinoma | 119 | 73.5 | Medium confidence | civicgdc | inputs
ranking row 2590501 |
| 139 | = | Serous Adenocarcinoma | 119 | 73.5 | Medium confidence | civicgdc | inputs
ranking row 2590499 |
| 148 | = | Clear Cell Adenocarcinoma | 117 | 71.7 | Medium confidence | civicgdc | inputs
ranking row 2590502 |
| 148 | = | Clear Cell Renal Cell Carcinoma | 117 | 71.7 | Medium confidence | civicgdc | inputs
ranking row 2590503 |
| 150 | = | Malignant Nervous System Neoplasm | 113 | 71.3 | Medium confidence | civicgdc | inputs
ranking row 2590504 |
| 151 | = | Exocrine Pancreas Carcinoma | 112 | 71.2 | Medium confidence | civicgdc | inputs
ranking row 2590508 |
| 151 | = | Malignant Exocrine Pancreas Neoplasm | 112 | 71.2 | Medium confidence | civicgdc | inputs
ranking row 2590506 |
| 151 | = | Malignant Pancreatic Neoplasm | 112 | 71.2 | Medium confidence | civicgdc | inputs
ranking row 2590505 |
| 151 | = | Pancreatic Adenocarcinoma | 112 | 71.2 | Medium confidence | civicgdc | inputs
ranking row 2590509 |
| 151 | = | Pancreatic Carcinoma | 112 | 71.2 | Medium confidence | civicgdc | inputs
ranking row 2590507 |
| 156 | = | Malignant Central Nervous System Neoplasm | 111 | 70.2 | Medium confidence | civicgdc | inputs
ranking row 2590510 |
| 157 | = | Malignant Eye Neoplasm | 104 | 70 | Medium confidence | civicgdc | inputs
ranking row 2590511 |
| 158 | = | Chromophobe Renal Cell Carcinoma | 103 | 69.8 | Medium confidence | civicgdc | inputs
ranking row 2590521 |
| 158 | = | Differentiated Thyroid Gland Carcinoma | 103 | 69.8 | Medium confidence | civicgdc | inputs
ranking row 2590518 |
| 158 | = | Head and Neck Adenocarcinoma | 103 | 69.8 | Medium confidence | civicgdc | inputs
ranking row 2590516 |
| 158 | = | Malignant Uveal Neoplasm | 103 | 69.8 | Medium confidence | civicgdc | inputs
ranking row 2590512 |
| 158 | = | Non-Cutaneous Melanoma | 103 | 69.8 | Medium confidence | civicgdc | inputs
ranking row 2590513 |
| 158 | = | Ocular Melanoma | 103 | 69.8 | Medium confidence | civicgdc | inputs
ranking row 2590514 |
| 158 | = | Papillary Renal Cell Carcinoma | 103 | 69.8 | Medium confidence | civicgdc | inputs
ranking row 2590519 |
| 158 | = | Thyroid Gland Adenocarcinoma | 103 | 69.8 | Medium confidence | civicgdc | inputs
ranking row 2590517 |
| 158 | = | Thyroid Gland Papillary Carcinoma | 103 | 69.8 | Medium confidence | civicgdc | inputs
ranking row 2590520 |
| 158 | = | Uveal Melanoma | 103 | 69.8 | Medium confidence | civicgdc | inputs
ranking row 2590515 |
| 168 | = | Carcinosarcoma | 102 | 67.9 | Medium confidence | civicgdc | inputs
ranking row 2590522 |
| 168 | = | Female Reproductive System Carcinosarcoma | 102 | 67.9 | Medium confidence | civicgdc | inputs
ranking row 2590523 |
| 168 | = | Uterine Carcinosarcoma | 102 | 67.9 | Medium confidence | civicgdc | inputs
ranking row 2590524 |
| 171 | = | Precursor Lymphoid Neoplasm | 101 | 67.3 | Medium confidence | civicgdc | inputs
ranking row 2590525 |
| 172 | = | Acute Lymphoblastic Leukemia | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590530 |
| 172 | = | Adult-Type Diffuse Glioma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590542 |
| 172 | = | Anaplastic Malignant Neoplasm | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590526 |
| 172 | = | Breast Invasive Carcinoma, NOS | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590543 |
| 172 | = | Burkitt Lymphoma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590538 |
| 172 | = | Cystadenocarcinoma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590527 |
| 172 | = | Encapsulated Glioma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590541 |
| 172 | = | Glioblastoma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590531 |
| 172 | = | High Grade Astrocytic Tumor | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590539 |
| 172 | = | Lymphoid Leukemia | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590532 |
| 172 | = | Malignant Glioma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590536 |
| 172 | = | Malignant Mesothelioma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590528 |
| 172 | = | Osteosarcoma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590533 |
| 172 | = | Ovarian Cystadenocarcinoma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590534 |
| 172 | = | Ovarian Serous Cystadenocarcinoma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590537 |
| 172 | = | Serous Cystadenocarcinoma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590535 |
| 172 | = | WHO Grade 4 Glioma | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590540 |
| 172 | = | Wilms Tumor | 100 | 67.1 | Medium confidence | civicgdc | inputs
ranking row 2590529 |
| 190 | = | Multiple Myeloma | 61 | 63.7 | Medium confidence | civicgdc | inputs
ranking row 2590544 |
| 191 | = | Cervical Squamous Cell Carcinoma | 47 | 63.5 | Medium confidence | civicgdc | inputs
ranking row 2590545 |
| 191 | = | Female Reproductive System Squamous Cell Carcinoma | 47 | 63.5 | Medium confidence | civicgdc | inputs
ranking row 2590546 |
| 193 | = | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 44 | 63.1 | Medium confidence | civicgdc | inputs
ranking row 2590552 |
| 193 | = | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile | 44 | 63.1 | Medium confidence | civicgdc | inputs
ranking row 2590553 |
| 193 | = | Diffuse Large B-Cell Lymphoma Unclassifiable | 44 | 63.1 | Medium confidence | civicgdc | inputs
ranking row 2590550 |
| 193 | = | Lung Neuroendocrine Carcinoma | 44 | 63.1 | Medium confidence | civicgdc | inputs
ranking row 2590548 |
| 193 | = | Lung Small Cell Carcinoma | 44 | 63.1 | Medium confidence | civicgdc | inputs
ranking row 2590551 |
| 193 | = | Neuroendocrine Carcinoma | 44 | 63.1 | Medium confidence | civicgdc | inputs
ranking row 2590547 |
| 193 | = | Small Cell Neuroendocrine Carcinoma | 44 | 63.1 | Medium confidence | civicgdc | inputs
ranking row 2590549 |
| 200 | = | Esophageal Adenocarcinoma | 42 | 61.7 | Medium confidence | civicgdc | inputs
ranking row 2590554 |
| 201 | = | Myelodysplastic Syndrome | 27 | 61.5 | Medium confidence | civicgdc | inputs
ranking row 2590555 |
| 202 | = | B Lymphoblastic Leukemia/Lymphoma | 23 | 61.3 | Medium confidence | civicgdc | inputs
ranking row 2590556 |
| 203 | = | Chronic Leukemia | 20 | 61.2 | Medium confidence | civicgdc | inputs
ranking row 2590557 |
| 204 | = | High-Grade Serous Ovarian Cancer | 19 | 61 | Medium confidence | civicgdc | inputs
ranking row 2590558 |
| 205 | = | Adenoid Cystic Carcinoma | 17 | 60.8 | Medium confidence | civicgdc | inputs
ranking row 2590559 |
| 205 | = | Malignant Salivary Gland Neoplasm | 17 | 60.8 | Medium confidence | civicgdc | inputs
ranking row 2590560 |
| 205 | = | Salivary Gland Carcinoma | 17 | 60.8 | Medium confidence | civicgdc | inputs
ranking row 2590561 |
| 208 | = | Acute Myeloid Leukemia with Genetic Abnormalities | 15 | 60.2 | Medium confidence | civicgdc | inputs
ranking row 2590564 |
| 208 | = | Malignant Soft Tissue Neoplasm | 15 | 60.2 | Medium confidence | civicgdc | inputs
ranking row 2590562 |
| 208 | = | Soft Tissue Sarcoma | 15 | 60.2 | Medium confidence | civicgdc | inputs
ranking row 2590563 |
| 211 | = | Malignant Brain Neoplasm | 14 | 59.6 | Medium confidence | civicgdc | inputs
ranking row 2590567 |
| 211 | = | Malignant Intracranial Neoplasm | 14 | 59.6 | Medium confidence | civicgdc | inputs
ranking row 2590566 |
| 211 | = | Malignant Musculoskeletal Neoplasm | 14 | 59.6 | Medium confidence | civicgdc | inputs
ranking row 2590565 |
| 214 | = | B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities | 13 | 59 | Medium confidence | civicgdc | inputs
ranking row 2590570 |
| 214 | = | Breast Adenocarcinoma | 13 | 59 | Medium confidence | civicgdc | inputs
ranking row 2590568 |
| 214 | = | Castration-Resistant Prostate Carcinoma | 13 | 59 | Medium confidence | civicgdc | inputs
ranking row 2590569 |
| 217 | = | Breast Carcinoma by Gene Expression Profile | 11 | 58.5 | Medium confidence | civicgdc | inputs
ranking row 2590574 |
| 217 | = | Childhood Malignant Neoplasm | 11 | 58.5 | Medium confidence | civicgdc | inputs
ranking row 2590571 |
| 217 | = | Chronic Lymphocytic Leukemia | 11 | 58.5 | Medium confidence | civicgdc | inputs
ranking row 2590573 |
| 217 | = | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 11 | 58.5 | Medium confidence | civicgdc | inputs
ranking row 2590572 |
| 221 | = | Pancreatic Ductal Adenocarcinoma | 10 | 57.7 | Medium confidence | civicgdc | inputs
ranking row 2590575 |
| 222 | = | B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like | 9 | 57.5 | Medium confidence | civicgdc | inputs
ranking row 2590583 |
| 222 | = | Gallbladder Carcinoma | 9 | 57.5 | Medium confidence | civicgdc | inputs
ranking row 2590584 |
| 222 | = | Malignant Gallbladder Neoplasm | 9 | 57.5 | Medium confidence | civicgdc | inputs
ranking row 2590578 |
| 222 | = | Malignant Muscle Neoplasm | 9 | 57.5 | Medium confidence | civicgdc | inputs
ranking row 2590576 |
| 222 | = | Myosarcoma | 9 | 57.5 | Medium confidence | civicgdc | inputs
ranking row 2590577 |
| 222 | = | Renal Pelvis and Ureter Carcinoma | 9 | 57.5 | Medium confidence | civicgdc | inputs
ranking row 2590579 |
| 222 | = | Renal Pelvis and Ureter Urothelial Carcinoma | 9 | 57.5 | Medium confidence | civicgdc | inputs
ranking row 2590585 |
| 222 | = | Rhabdomyosarcoma | 9 | 57.5 | Medium confidence | civicgdc | inputs
ranking row 2590580 |
| 222 | = | Small Lymphocytic Lymphoma | 9 | 57.5 | Medium confidence | civicgdc | inputs
ranking row 2590581 |
| 222 | = | T-Cell Non-Hodgkin Lymphoma | 9 | 57.5 | Medium confidence | civicgdc | inputs
ranking row 2590582 |
| 232 | = | Ewing Sarcoma | 8 | 55.6 | Medium confidence | civicgdc | inputs
ranking row 2590586 |
| 232 | = | Head and Neck Carcinoma, Other | 8 | 55.6 | Medium confidence | civicgdc | inputs
ranking row 2590589 |
| 232 | = | HER2-Positive Breast Carcinoma | 8 | 55.6 | Medium confidence | civicgdc | inputs
ranking row 2590588 |
| 232 | = | Malignant Soft Tissue Neoplasm of Uncertain Differentiation | 8 | 55.6 | Medium confidence | civicgdc | inputs
ranking row 2590587 |
| 236 | = | Ampulla of Vater Carcinoma | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590602 |
| 236 | = | B Acute Lymphoblastic Leukemia | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590596 |
| 236 | = | Central Nervous System Embryonal Tumor | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590590 |
| 236 | = | Childhood Sarcoma | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590592 |
| 236 | = | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590597 |
| 236 | = | Intrahepatic Cholangiocarcinoma | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590598 |
| 236 | = | Malignant Ampulla of Vater Neoplasm | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590600 |
| 236 | = | Malignant Cerebellar Neoplasm | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590604 |
| 236 | = | Malignant Infratentorial Neoplasm | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590603 |
| 236 | = | Malignant Small Intestinal Neoplasm | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590599 |
| 236 | = | Medulloblastoma | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590593 |
| 236 | = | Neuroblastic Tumor | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590594 |
| 236 | = | Primitive Neuroectodermal Tumor | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590591 |
| 236 | = | Small Cell Sarcoma | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590595 |
| 236 | = | Small Intestinal Carcinoma | 7 | 54.8 | Medium confidence | civicgdc | inputs
ranking row 2590601 |
| 251 | = | Anaplastic Astrocytoma | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590605 |
| 251 | = | Appendix Adenocarcinoma | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590613 |
| 251 | = | Appendix Carcinoma | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590609 |
| 251 | = | Childhood Malignant Genitourinary System Neoplasm | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590606 |
| 251 | = | Childhood Malignant Kidney Neoplasm | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590610 |
| 251 | = | Esophageal Squamous Cell Carcinoma | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590611 |
| 251 | = | Malignant Appendix Neoplasm | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590607 |
| 251 | = | Malignant Supratentorial Neoplasm | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590615 |
| 251 | = | Myelodysplastic/Myeloproliferative Neoplasm | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590608 |
| 251 | = | Neuroblastoma | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590612 |
| 251 | = | Non-Seminomatous Germ Cell Tumor | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590616 |
| 251 | = | WHO Grade 3 Glioma | 6 | 51.9 | Medium confidence | civicgdc | inputs
ranking row 2590614 |
| 263 | = | AML with Recurrent Genetic Abnormalities | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590633 |
| 263 | = | Bone Ewing Sarcoma | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590622 |
| 263 | = | Bone Sarcoma | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590618 |
| 263 | = | Childhood Soft Tissue Sarcoma | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590623 |
| 263 | = | Clear Cell Sarcoma of the Kidney | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590626 |
| 263 | = | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590619 |
| 263 | = | Extrapulmonary Neuroendocrine Carcinoma | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590624 |
| 263 | = | High-Grade Glioma, NOS | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590632 |
| 263 | = | Kidney Sarcoma | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590625 |
| 263 | = | Liposarcoma | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590620 |
| 263 | = | Malignant Bone Neoplasm | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590621 |
| 263 | = | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590627 |
| 263 | = | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590629 |
| 263 | = | Spindle Cell Rhabdomyosarcoma | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590630 |
| 263 | = | Spindle Cell/Sclerosing Rhabdomyosarcoma | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590628 |
| 263 | = | Supratentorial Ependymoma ZFTA Fusion-Positive | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590631 |
| 263 | = | Thyroid Gland Follicular Carcinoma | 5 | 49.6 | Medium confidence | civicgdc | inputs
ranking row 2590617 |
| 280 | = | Acral Lentiginous Melanoma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590650 |
| 280 | = | Acral Melanoma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590646 |
| 280 | = | Acute Promyelocytic Leukemia | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590653 |
| 280 | = | Brain Glioblastoma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590639 |
| 280 | = | Central Nervous System Lymphoma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590634 |
| 280 | = | Chondrosarcoma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590635 |
| 280 | = | Combined Hepatocellular Carcinoma and Cholangiocarcinoma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590640 |
| 280 | = | Cutaneous Melanoma of the Extremity | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590641 |
| 280 | = | Diffuse Midline Glioma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590647 |
| 280 | = | Diffuse Midline Glioma, H3 K27-Altered | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590651 |
| 280 | = | Fibrosarcoma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590636 |
| 280 | = | Kidney Carcinoma Molecular Subtypes | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590652 |
| 280 | = | Lymphoma by Site | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590637 |
| 280 | = | Malignant Brain Glioma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590648 |
| 280 | = | Malignant Mixed Mesodermal (Mullerian) Tumor | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590638 |
| 280 | = | Mantle Cell Lymphoma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590649 |
| 280 | = | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590642 |
| 280 | = | Pediatric-Type Diffuse High-Grade Glioma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590655 |
| 280 | = | Pediatric-Type Diffuse Low-Grade Glioma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590654 |
| 280 | = | Primary Central Nervous System Lymphoma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590643 |
| 280 | = | Synovial Sarcoma | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590644 |
| 280 | = | Uterine Malignant Mixed Mesodermal (Mullerian) Tumor | 4 | 46.3 | Medium confidence | civicgdc | inputs
ranking row 2590645 |
| 302 | = | Adenosquamous Carcinoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590665 |
| 302 | = | Chronic Myelomonocytic Leukemia | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590666 |
| 302 | = | Classic Hodgkin Lymphoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590667 |
| 302 | = | Follicular Lymphoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590672 |
| 302 | = | Head and Neck Mucosal Squamous Cell Carcinoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590668 |
| 302 | = | Head and Neck Undifferentiated Carcinoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590669 |
| 302 | = | Hodgkin Lymphoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590656 |
| 302 | = | Large Cell Carcinoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590657 |
| 302 | = | Malignant Head and Neck Mucosal Neoplasm | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590658 |
| 302 | = | Malignant Peripheral Nerve Sheath Tumor | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590659 |
| 302 | = | Malignant Peripheral Nervous System Neoplasm | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590660 |
| 302 | = | Mixed Carcinoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590661 |
| 302 | = | Mucosal Melanoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590670 |
| 302 | = | Primary Myelofibrosis | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590673 |
| 302 | = | Renal Cell Carcinoma with MiT Translocations | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590674 |
| 302 | = | Spindle Cell Sarcoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590662 |
| 302 | = | Thyroid Gland Anaplastic Carcinoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590671 |
| 302 | = | T Lymphoblastic Leukemia/Lymphoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590663 |
| 302 | = | Triple-Negative Breast Carcinoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590675 |
| 302 | = | Undifferentiated Carcinoma | 3 | 42.1 | Medium confidence | civicgdc | inputs
ranking row 2590664 |
| 322 | = | Acinar Cell Carcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590684 |
| 322 | = | Adult Acute Lymphoblastic Leukemia | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590685 |
| 322 | = | Adult B Acute Lymphoblastic Leukemia | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590700 |
| 322 | = | Angiosarcoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590701 |
| 322 | = | Atypical Chronic Myeloid Leukemia | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590686 |
| 322 | = | Breast Inflammatory Carcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590702 |
| 322 | = | Carcinomatosis | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590687 |
| 322 | = | Childhood Acute Leukemia | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590688 |
| 322 | = | Childhood Fibrosarcoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590689 |
| 322 | = | Childhood Leukemia | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590677 |
| 322 | = | Core Binding Factor Acute Myeloid Leukemia | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590714 |
| 322 | = | Hairy Cell Leukemia | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590678 |
| 322 | = | Infantile Fibrosarcoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590703 |
| 322 | = | Laryngeal Carcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590704 |
| 322 | = | Lip and Oral Cavity Carcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590690 |
| 322 | = | Lip and Oral Cavity Squamous Cell Carcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590705 |
| 322 | = | Lung Adenosquamous Carcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590706 |
| 322 | = | Malignant Blood Vessel Neoplasm | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590691 |
| 322 | = | Malignant Cardiovascular Neoplasm | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590676 |
| 322 | = | Malignant Laryngeal Neoplasm | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590692 |
| 322 | = | Malignant Lip and Oral Cavity Neoplasm | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590679 |
| 322 | = | Malignant Oral Cavity Neoplasm | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590693 |
| 322 | = | Malignant Pleural Neoplasm | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590680 |
| 322 | = | Malignant Vascular Neoplasm | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590681 |
| 322 | = | Merkel Cell Carcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590707 |
| 322 | = | Minimally Invasive Lung Adenocarcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590713 |
| 322 | = | Mucinous Adenocarcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590694 |
| 322 | = | Myxoid Liposarcoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590695 |
| 322 | = | Oral Cavity Carcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590708 |
| 322 | = | Oral Cavity Squamous Cell Carcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590709 |
| 322 | = | Peritoneal Carcinomatosis | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590710 |
| 322 | = | Pleural Malignant Mesothelioma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590682 |
| 322 | = | Pseudomyxoma Peritonei | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590711 |
| 322 | = | Round Cell Sarcoma with EWSR1-non-ETS Fusion | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590696 |
| 322 | = | Sarcoma with BCOR Genetic Alterations | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590697 |
| 322 | = | Secondary Carcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590683 |
| 322 | = | T Acute Lymphoblastic Leukemia | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590698 |
| 322 | = | Throat Carcinoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590712 |
| 322 | = | Uterine Corpus Sarcoma | 2 | 38.3 | Medium confidence | civicgdc | inputs
ranking row 2590699 |
| 361 | = | Acute Leukemia of Ambiguous Lineage | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590747 |
| 361 | = | Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590856 |
| 361 | = | Acute Myeloid Leukemia with BCR-ABL1 | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590857 |
| 361 | = | Acute Myeloid Leukemia with CEBPA Mutation | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590858 |
| 361 | = | Acute Myeloid Leukemia with FUS-ERG | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590859 |
| 361 | = | Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590868 |
| 361 | = | Acute Myeloid Leukemia with KMT2A Rearrangement | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590860 |
| 361 | = | Acute Myeloid Leukemia with MECOM Rearrangement | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590861 |
| 361 | = | Acute Myeloid Leukemia with NPM1-MLF1 | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590863 |
| 361 | = | Acute Myeloid Leukemia with NPM1 Mutation | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590862 |
| 361 | = | Acute Myeloid Leukemia with NUP98 Rearrangement | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590864 |
| 361 | = | Acute Myeloid Leukemia with t(8;16)(p11.2;p13.3); KAT6A-CREBBP | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590865 |
| 361 | = | Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590869 |
| 361 | = | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590870 |
| 361 | = | Adult Lymphoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590720 |
| 361 | = | Adult Non-Hodgkin Lymphoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590748 |
| 361 | = | Adult T-Cell Leukemia/Lymphoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590749 |
| 361 | = | Aggressive Adult Non-Hodgkin Lymphoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590794 |
| 361 | = | Aggressive T-Cell Non-Hodgkin Lymphoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590795 |
| 361 | = | Alveolar Rhabdomyosarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590796 |
| 361 | = | Alveolar Soft Part Sarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590750 |
| 361 | = | Anal Melanoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590797 |
| 361 | = | Anaplastic Ependymoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590721 |
| 361 | = | Anaplastic Large Cell Lymphoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590722 |
| 361 | = | Anorectal Melanoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590751 |
| 361 | = | Atypical Teratoid/Rhabdoid Tumor | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590723 |
| 361 | = | B Acute Lymphoblastic Leukemia with DUX4 Rearrangement | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590840 |
| 361 | = | B Acute Lymphoblastic Leukemia with PAX5 P80R Mutation | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590841 |
| 361 | = | B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); TCF3-PBX1 | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590842 |
| 361 | = | Barrett Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590752 |
| 361 | = | Bile Duct Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590843 |
| 361 | = | Biliary Tract Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590804 |
| 361 | = | B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590798 |
| 361 | = | B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590799 |
| 361 | = | B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590800 |
| 361 | = | B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590801 |
| 361 | = | B Lymphoblastic Leukemia/Lymphoma with TCF3-HLF Rearrangement | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590803 |
| 361 | = | B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590802 |
| 361 | = | Breast Secretory Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590805 |
| 361 | = | Breast Tubular Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590806 |
| 361 | = | Central Nervous System Neuroblastoma, FOXR2-Activated | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590807 |
| 361 | = | Central Nervous System Tumor with BCOR Internal Tandem Duplication | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590724 |
| 361 | = | Cervical Sarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590753 |
| 361 | = | Childhood Acute Lymphoblastic Leukemia | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590754 |
| 361 | = | Childhood Acute Myeloid Leukemia | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590808 |
| 361 | = | Childhood Central Nervous System Embryonal Tumor | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590725 |
| 361 | = | Childhood Malignant Brain Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590809 |
| 361 | = | Childhood Malignant Central Nervous System Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590755 |
| 361 | = | Childhood Malignant Nervous System Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590726 |
| 361 | = | Childhood Medulloblastoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590756 |
| 361 | = | Cholangiolocellular Small Duct Intrahepatic Cholangiocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590844 |
| 361 | = | Chordoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590715 |
| 361 | = | Chronic Neutrophilic Leukemia | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590757 |
| 361 | = | CIC-Rearranged Sarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590810 |
| 361 | = | Clear Cell Sarcoma of Soft Tissue | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590758 |
| 361 | = | Colon Mucinous Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590845 |
| 361 | = | Colorectal Mucinous Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590811 |
| 361 | = | Congenital Mesoblastic Nephroma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590716 |
| 361 | = | Cribriform Neuroepithelial Tumor | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590727 |
| 361 | = | Desmoplastic Small Round Cell Tumor | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590759 |
| 361 | = | Diffuse Large B-Cell Lymphoma Activated B-Cell Type | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590812 |
| 361 | = | Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590871 |
| 361 | = | Digestive System Adenosquamous Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590760 |
| 361 | = | Digestive System Mucosal Melanoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590728 |
| 361 | = | Digestive System Neuroendocrine Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590729 |
| 361 | = | Distal Esophagus Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590846 |
| 361 | = | Endometrial Serous Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590813 |
| 361 | = | Epithelioid Sarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590761 |
| 361 | = | Erythroid Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590730 |
| 361 | = | Essential Thrombocythemia | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590762 |
| 361 | = | EWSR1-Negative Small Round Cell Tumor | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590763 |
| 361 | = | Extramammary Paget Disease | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590814 |
| 361 | = | Extrapulmonary Small Cell Neuroendocrine Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590815 |
| 361 | = | Extraskeletal Myxoid Chondrosarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590764 |
| 361 | = | Fibrolamellar Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590816 |
| 361 | = | Ganglioneuroblastoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590765 |
| 361 | = | Gastric Adenosquamous Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590817 |
| 361 | = | Gastroblastoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590766 |
| 361 | = | Glioblastoma, IDH-Wildtype | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590767 |
| 361 | = | Gliosarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590818 |
| 361 | = | Head and Neck Adenoid Cystic Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590768 |
| 361 | = | Head and Neck Neuroendocrine Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590731 |
| 361 | = | High Grade Endometrial Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590847 |
| 361 | = | High Grade Follicular Cell-Derived Non-Anaplastic Thyroid Gland Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590819 |
| 361 | = | Histiocytic Sarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590732 |
| 361 | = | HTLV-1-Related Malignant Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590769 |
| 361 | = | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590820 |
| 361 | = | Indolent Non-Hodgkin Lymphoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590821 |
| 361 | = | Infection-Related Malignant Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590717 |
| 361 | = | Invasive Bladder Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590770 |
| 361 | = | Invasive Bladder Urothelial Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590822 |
| 361 | = | Invasive Lung Non-Mucinous Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590771 |
| 361 | = | Invasive Urothelial Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590772 |
| 361 | = | Juvenile Myelomonocytic Leukemia | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590733 |
| 361 | = | Kidney Medullary Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590848 |
| 361 | = | Kidney Wilms Tumor | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590734 |
| 361 | = | Langerhans Cell Sarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590735 |
| 361 | = | Large B-Cell Lymphoma with IRF4 Rearrangement | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590823 |
| 361 | = | Laryngeal Squamous Cell Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590824 |
| 361 | = | Leukemic Phase of Non-Hodgkin Lymphoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590773 |
| 361 | = | Low Grade Fibromyxoid Sarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590774 |
| 361 | = | Low-Grade Serous Ovarian Cancer | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590874 |
| 361 | = | Lung Acinar Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590825 |
| 361 | = | Lymphoplasmacytic Lymphoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590849 |
| 361 | = | Malignant Anal Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590850 |
| 361 | = | Malignant Esophageal Neoplasm by Topographic Region | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590775 |
| 361 | = | Malignant Histiocytic and Dendritic Cell Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590718 |
| 361 | = | Malignant Neoplasm of the Lower Third of the Esophagus | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590826 |
| 361 | = | Malignant Oropharyngeal Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590827 |
| 361 | = | Malignant Ovarian Brenner Tumor | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590776 |
| 361 | = | Malignant Ovarian Endometrioid Tumor | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590777 |
| 361 | = | Malignant Pharyngeal Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590778 |
| 361 | = | Malignant Retinal Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590736 |
| 361 | = | Malignant Scrotal Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590737 |
| 361 | = | Malignant Thymus Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590738 |
| 361 | = | Malignant Ureter Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590828 |
| 361 | = | Malignant Vaginal Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590829 |
| 361 | = | Medulloblastoma Molecular Subtypes | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590779 |
| 361 | = | Medulloblastoma, SHH-Activated | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590830 |
| 361 | = | Megakaryocytic Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590739 |
| 361 | = | Mesenchymal Chondrosarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590780 |
| 361 | = | Metaplastic Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590740 |
| 361 | = | Mucin-Producing Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590741 |
| 361 | = | Mucoepidermoid Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590781 |
| 361 | = | Mycosis Fungoides and Sezary Syndrome | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590851 |
| 361 | = | Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590719 |
| 361 | = | NUT Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590742 |
| 361 | = | Oncocytic Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590782 |
| 361 | = | Ovarian Endometrioid Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590831 |
| 361 | = | Paget Disease | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590783 |
| 361 | = | Pancreatic Acinar Cell Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590832 |
| 361 | = | Pancreatic Neuroendocrine Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590784 |
| 361 | = | Polycythemia Vera | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590785 |
| 361 | = | Poorly Differentiated Thyroid Gland Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590852 |
| 361 | = | Primary CNS Melanocytic Tumors | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590872 |
| 361 | = | Renal Medullary Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590875 |
| 361 | = | Retinoblastoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590786 |
| 361 | = | Salivary Gland Adenoid Cystic Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590833 |
| 361 | = | Salivary Gland Mucoepidermoid Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590834 |
| 361 | = | Sclerosing Epithelioid Fibrosarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590787 |
| 361 | = | Scrotal Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590788 |
| 361 | = | Scrotal Paget Disease | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590835 |
| 361 | = | Sezary Syndrome | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590836 |
| 361 | = | Small Duct Intrahepatic Cholangiocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590837 |
| 361 | = | SMARCB1-Deficient Kidney Medullary Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590866 |
| 361 | = | Spitzoid Melanoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590873 |
| 361 | = | T-Cell Large Granular Lymphocyte Leukemia | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590789 |
| 361 | = | TFE3-Rearranged Renal Cell Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590867 |
| 361 | = | Thymus Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590743 |
| 361 | = | Thyroid Gland Medullary Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590790 |
| 361 | = | Thyroid Gland Oncocytic Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590744 |
| 361 | = | Tubular Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590791 |
| 361 | = | Type II Endometrial Adenocarcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590853 |
| 361 | = | Ureter Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590838 |
| 361 | = | Ureter Small Cell Neuroendocrine Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590854 |
| 361 | = | Urinary Tract Neuroendocrine Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590792 |
| 361 | = | Urinary Tract Non-Urothelial Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590855 |
| 361 | = | Urinary Tract Small Cell Neuroendocrine Carcinoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590839 |
| 361 | = | Vaginal Sarcoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590793 |
| 361 | = | Virus-Related Lymphoma | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590745 |
| 361 | = | Virus-Related Malignant Neoplasm | 1 | 30.8 | Medium confidence | civicgdc | inputs
ranking row 2590746 |
Data updated 16 hours agoSource updated unknown521 eligible entities · inputs hash dc02edfbbd5b601934401df4